Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3501622019 | Carbidopa 10 mg and levodopa 100 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677283016 | Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing levodopa (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Carbidopa | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Levodopa (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Levodopa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Carbidopa | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Levodopa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Carbidopa | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Is a | Product containing only carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Co-careldopa 10mg/100mg tablet | Is a | False | Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR